• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可能的肌肉减少症、肥胖与全因死亡率风险:4612 名参与者的汇总分析。

Probable Sarcopenia, Obesity, and Risk of All-Cause Mortality: A Pooled Analysis of 4,612 Participants.

机构信息

Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.

Department of Public Health, University of Turku and Turku University Hospital, Turku, Finland.

出版信息

Gerontology. 2023;69(6):706-715. doi: 10.1159/000527804. Epub 2023 Jan 30.

DOI:10.1159/000527804
PMID:36716714
Abstract

INTRODUCTION

Conflicting evidence exists concerning whether having sarcopenic obesity has additive mortality risk over having only sarcopenia or obesity. We examined the independent and combined associations of obesity and probable sarcopenia with all-cause mortality.

METHODS

The pooled analysis included three large, harmonized datasets (Health 2000 Survey; Health, Aging and Body Composition Study; Longitudinal Aging Study Amsterdam) with mortality follow-up data on individuals aged 70 years and over at baseline (n = 4,612). Obesity indicators included body mass index and waist circumference, and probable sarcopenia was defined based on grip strength. The mixed effects Cox model was used for statistical analyses, adjusting for age, sex, marital status, education, race, physical activity, alcohol consumption, smoking, and baseline diseases.

RESULTS

Risk of death increased for those having probable sarcopenia only (hazard ratio [HR]: 1.61, 95% confidence interval [CI]: 1.39-1.85) or probable sarcopenia with obesity (HR: 1.36, 95% CI: 1.13-1.64) but not for the obese-only group (HR: 0.92, 95% CI: 0.85-1.01), when compared to non-obese non-sarcopenic individuals. The results were similar regardless of adjustments for covariates or different obesity criteria applied.

CONCLUSION

Probable sarcopenia, whether combined with obesity or not, is associated with increased mortality. Obesity did not increase mortality among older adults. Maintaining muscle strength and identifying older adults at risk of sarcopenia is important for the prevention of premature mortality.

摘要

简介

关于肥胖合并肌肉减少症是否比单独存在肌肉减少症或肥胖具有更高的死亡风险,目前存在相互矛盾的证据。我们研究了肥胖和可能的肌肉减少症与全因死亡率的独立和联合关联。

方法

这项汇总分析纳入了三个大型、协调一致的数据集(健康 2000 调查;健康、衰老和身体成分研究;阿姆斯特丹纵向老龄化研究),这些数据均具有在基线时年龄在 70 岁及以上的个体的死亡率随访数据(n=4612)。肥胖指标包括体重指数和腰围,而可能的肌肉减少症则根据握力来定义。采用混合效应 Cox 模型进行统计分析,调整了年龄、性别、婚姻状况、教育程度、种族、身体活动、酒精摄入量、吸烟情况和基线疾病。

结果

与非肥胖非肌肉减少症个体相比,仅存在可能的肌肉减少症(危险比 [HR]:1.61,95%置信区间 [CI]:1.39-1.85)或可能的肌肉减少症合并肥胖(HR:1.36,95% CI:1.13-1.64)的个体死亡风险增加,但肥胖个体(HR:0.92,95% CI:0.85-1.01)的死亡风险并未增加。无论调整协变量还是应用不同的肥胖标准,结果均相似。

结论

无论是否合并肥胖,可能的肌肉减少症均与死亡率增加相关。肥胖并未增加老年人的死亡率。保持肌肉力量和识别有肌肉减少症风险的老年人对于预防过早死亡至关重要。

相似文献

1
Probable Sarcopenia, Obesity, and Risk of All-Cause Mortality: A Pooled Analysis of 4,612 Participants.可能的肌肉减少症、肥胖与全因死亡率风险:4612 名参与者的汇总分析。
Gerontology. 2023;69(6):706-715. doi: 10.1159/000527804. Epub 2023 Jan 30.
2
Sarcopenic obesity, weight loss, and mortality: the English Longitudinal Study of Ageing.肌少症性肥胖、体重减轻与死亡率:英国老龄化纵向研究
Am J Clin Nutr. 2017 Jul;106(1):125-129. doi: 10.3945/ajcn.117.152488. Epub 2017 May 24.
3
Sarcopenia and Sarcopenic Obesity and Mortality Among Older People.老年人的肌肉减少症和肌少症性肥胖与死亡率。
JAMA Netw Open. 2024 Mar 4;7(3):e243604. doi: 10.1001/jamanetworkopen.2024.3604.
4
Associations between Body Mass Index and Probable Sarcopenia in Community-Dwelling Older Adults.社区居住的老年人中体质指数与可能的肌肉减少症之间的关联。
Nutrients. 2023 Mar 21;15(6):1505. doi: 10.3390/nu15061505.
5
Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III.老年人的肌肉减少症、肌肉减少性肥胖与死亡率:来自第三次全国健康与营养检查调查的结果
Eur J Clin Nutr. 2014 Sep;68(9):1001-7. doi: 10.1038/ejcn.2014.117. Epub 2014 Jun 25.
6
The association between sarcopenic obesity, sarcopenia and functional dependence, malnutrition, and mortality: the phenomenon of obesity paradox in sarcopenic obesity.肌少症性肥胖、肌少症与功能依赖、营养不良及死亡率之间的关联:肌少症性肥胖中的肥胖悖论现象
Eur Geriatr Med. 2025 Feb;16(1):89-97. doi: 10.1007/s41999-024-01139-y. Epub 2025 Jan 11.
7
The distinct impacts of sarcopenic and dynapenic obesity on mortality in middle-aged and older adults based on different adiposity metrics: Results from I-Lan Longitudinal Aging Study.基于不同肥胖指标,基于肌肉减少性肥胖和动力性肥胖对中年和老年人死亡率的不同影响:来自宜兰纵向老龄化研究的结果。
Clin Nutr. 2024 Aug;43(8):1892-1899. doi: 10.1016/j.clnu.2024.06.035. Epub 2024 Jul 4.
8
Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men.肌肉减少性肥胖与心血管疾病和死亡风险:一项基于人群的老年男性队列研究。
J Am Geriatr Soc. 2014 Feb;62(2):253-60. doi: 10.1111/jgs.12652. Epub 2014 Jan 15.
9
Sarcopenic obesity and risk of new onset depressive symptoms in older adults: English Longitudinal Study of Ageing.肌肉减少性肥胖与老年人新发抑郁症状的风险:英国老龄化纵向研究
Int J Obes (Lond). 2015 Dec;39(12):1717-20. doi: 10.1038/ijo.2015.124. Epub 2015 Jun 30.
10
Association of sarcopenic obesity predicted by anthropometric measurements and 24-y all-cause mortality in elderly men: The Kuakini Honolulu Heart Program.人体测量学指标预测的肌少症性肥胖与老年男性 24 年全因死亡率的关系:库阿基尼·檀香山心脏研究计划。
Nutrition. 2018 Feb;46:97-102. doi: 10.1016/j.nut.2017.09.003. Epub 2017 Sep 21.

引用本文的文献

1
Association of possible sarcopenia and its components with all-cause mortality in a middle-aged and older population: a 9-year cohort study.中年及老年人群中潜在肌肉减少症及其组成部分与全因死亡率的关联:一项9年队列研究
Sci Rep. 2025 Aug 20;15(1):30481. doi: 10.1038/s41598-025-16034-0.
2
Predictors of Low Muscle Strength and Reduction in Fat-Free Mass in Multi-Ethnic Asian Populations Undergoing Bariatric-Metabolic Surgery.接受减重代谢手术的多民族亚洲人群中低肌肉力量和去脂体重减少的预测因素
Obes Surg. 2025 Jul 21. doi: 10.1007/s11695-025-08015-z.
3
Prevalence and influencing factors of sarcopenia among older adults in rural coastal areas of Ningbo City.
宁波市沿海农村地区老年人肌肉减少症的患病率及影响因素
Sci Rep. 2025 Feb 19;15(1):6037. doi: 10.1038/s41598-025-90017-z.
4
Bridging the Gap: Supplements Strategies from Experimental Research to Clinical Applications in Sarcopenic Obesity.弥合差距:从肌肉减少性肥胖的实验研究到临床应用的补充策略
Curr Issues Mol Biol. 2024 Nov 24;46(12):13418-13430. doi: 10.3390/cimb46120800.
5
Age-Related Changes in Insulin Resistance and Muscle Mass: Clinical Implications in Obese Older Adults.年龄相关性胰岛素抵抗和肌肉量变化:肥胖老年人群的临床意义。
Medicina (Kaunas). 2024 Oct 8;60(10):1648. doi: 10.3390/medicina60101648.
6
Risk of secondary sarcopenia in Europeans with fibromyalgia according to the EWGSOP2 guidelines: systematic review and meta-analysis.根据 EWGSOP2 指南,纤维肌痛欧洲患者发生继发性肌肉减少症的风险:系统评价和荟萃分析。
Eur J Phys Rehabil Med. 2024 Aug;60(4):703-715. doi: 10.23736/S1973-9087.24.08348-5. Epub 2024 Jun 11.
7
Sarcopenic Obesity and Cardiovascular Disease: An Overlooked but High-Risk Syndrome.肌肉减少性肥胖与心血管疾病:一个被忽视但高风险的综合征。
Curr Obes Rep. 2024 Sep;13(3):532-544. doi: 10.1007/s13679-024-00571-2. Epub 2024 May 16.
8
Sarcopenia and sarcopenic obesity among older adults in the nordic countries: a scoping review.北欧国家老年人的肌肉减少症和肌少症性肥胖症:范围综述。
BMC Geriatr. 2024 May 13;24(1):421. doi: 10.1186/s12877-024-04970-x.